Although multidetector row computed tomography is not the primary method of evaluating breast cancer, it could be performed as an excellent alternative, especially in the presence of magnetic resonance contraindications. Moreover, computed tomography can still have an important role in evaluation of nodal status, thoracic invasion, and distant metastasis because of the large area covered in a single examination. Our experience together with literature indicates that multidetector row computed tomography is a powerful supplementary method for evaluation of patients with breast cancer.Key Words: breast, breast neoplasm, multidetector row computed tomography (J Comput Assist Tomogr 2008;32:583Y598) T he first use of computed tomography (CT) in patients with breast cancer had been reported in 1977, using specially designed CT.1,2 Since then, a few reports have described the use of standard CT body scanners for diagnosis of breast lesions and reported an increase of CT values after contrast enhancement.3Y5 However, the conventional CT has restrictively been used under specific circumstances, such as dense breast, visualizing lesions located adjacent to the chest wall, presence of metastatic axillary lymph node (LN), CT-guided biopsy or localization, and planning for radiotherapy, because of limitation due to radiation exposure. 5 In 1989, helical CT was developed, and it reduced the motion artifact, magnified contrast enhancement effect, and improved the quality of multiplanar reconstruction or 3-dimensional image.6Y8 Multidetector row CT (MDCT) was first clinically available in 1998. It can detect smaller lesion and produces more detailed information about the extent of breast cancer because of faster scanning, a wider area of scan coverage, and higher resolution of the volume data than single helical CT. However, very few studies are now going on about the preoperative evaluation and staging workup in patients with breast cancer using MDCT. Therefore, we present our various experiences of MDCT in breast cancers.
SUBJECTS AND METHODS
PatientsDuring a 4-year period between March 2003 and March 2007, a total of 144 women underwent MDCT at our institute. Subjects comprised 139 women with histologically proven primary breast cancer, 3 women who were clinically suspected of having a tumor recurrence, and 2 women who underwent CT-guided biopsy for suspicious lesions on breast magnetic resonance imaging (MRI).Because of the problem of radiation exposure, we carefully applied the indication for MDCT. We first restricted the application of MDCT examination to only preoperative patients with histologically proven breast cancer. Because CT is not the primary method of evaluating specific breast lesions, we did not perform MDCT to differentiate malignancy from benign breast lesion. At our hospital during the study period, 1509 women were clinically suspected of having breast cancer based on physical examination, mammography, or ultrasonography, and 637 of them were diagnosed as primary breast cancer by percutaneous...